 |
Articles: Drug Trials |
Prior Articles
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week
Salix Pharmaceuticals, 06/02/09
Free full text
Phase III study data with vandetanib (ZACTIMA) in patients with advanced non-small cell lung cancer (NSCLC) presented at American Society of Clinical Oncology
AstraZeneca, 06/01/09
Free full text
Maintenance treatment with Avastin and Tarceva in combination helps lung cancer patients live longer without their disease worsening
Roche, 06/01/09
Free full text
Calcimimetics: A Review of the Recent Literature
Kidney, 06/01/09 VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome
Trials, 06/01/09
Free full text
Results from Three Phase 2 Studies Reported a Two-Year Survival Rate Ranging from 30 to 42 Percent in Metastatic Melanoma Patients Treated with Ipilimumab
Bristol Myers-Squibb Company, 06/01/09
Free full text
Exelixis and BMS Report Phase 2 Data to Be Presented at ASCO for XL184 in Patients with Previously Treated Glioblastoma Multiforme
Bristol Myers-Squibb Company, 06/01/09
Free full text
Subset Data from Two Randomized Phase 3 Trials Show TYSABRI(R) Significantly Improves Health-Related Quality of Life for Crohn's Disease Patients with Prior Exposure or Inadequate Response to Anti-TNFa Therapy
Elan, 06/01/09
Free full text
Investigational Cancer Drug BSI-201
Showed Clinical Benefit in 62% of Patients
with Triple-Negative Metastatic Breast Cancer and
Significantly Prolonged Survival
Sanofi-aventis, 06/01/09
Free full text
New Analyses from 16-Year Follow-up Trial with Betaseron Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
Bayer HealthCare Pharmaceuticals, 05/29/09
Free full text
Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
Bayer HealthCare Pharmaceuticals, 05/29/09
Free full text
First Phase III Data on Innovative Compound for Solid Organ Transplantation To be Featured at American Transplant Congress
Bristol Myers-Squibb Company, 05/29/09
Free full text
Outcome based subgroup analysis: a neglected concern
Trials, 05/29/09
Free full text
Over 50 years of trial in Acta Psychiatrica Scandinavica: a survey
Trials, 05/29/09
Free full text
GSK: Clinical Trials, African Style
PharmExec, 05/29/09 Designing clinical trials and experiments efficiently with the program package CADEMO
Contemporary Clinical Trials, 05/28/09 Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance
Contemporary Clinical Trials, 05/28/09 A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma
Cancer Chemotherapy and Pharmacology, 05/28/09 RISPERDAL CONSTA (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
Janssen, 05/28/09
Free full text
New Data Demonstrate RISPERDAL CONSTA (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia
Janssen, 05/28/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
